News

Recently added news items

BABCP Development Plan approved

Posted: 11th March 2010

The membership consultation on the draft BABCP Development Plan closed on Monday, 22nd February 2010. Members were asked to indicate whether or not they supported each objective in associated with the six strategic aims: 1) Core Business; 2) Internal and External Communications and Relationships; 3) Public Involvement; 4) Business...

Find out more


CB approach effective for subacute, chronic low back pain

Posted: 2nd March 2010

Readers may have seen news coverage of a large randomised controlled trial published in The Lancet in February (and available to view here), which showed clinical effectiveness of a cognitive-behavioural (CB) approach for subacute/chronic low back pain (LBP). This is an exciting result for both the world of LBP...

Find out more


Update on HPC Statutory Regulation

Posted: 2nd March 2010

At the January 2010 meeting of the BABCP National Committees Forum, Michael Guthrie, Director of Policy and Standards for the Health Professions Council (HPC), gave a helpful presentation on the current status of HPC Regulation of Psychotherapists and Counsellors. The HPC currently regulates 206,000 registrants, across 14 professions. The...

Find out more


BABCP Development Plan - Update

Posted: 1st March 2010

The membership consultation on the proposed BABCP Development Plan closed on Monday, 22nd February 2010. Just 40 responses were received, but the overall plan was viewed positively and supported by all respondents. Each objective relating to the six strategic aims contained in the plan received overwhelming endorsement from those...

Find out more


Wanted: Feedback from clinicians on treating Panic Disorder

Posted: 1st March 2010

In their efforts to build a two-way bridge between research and practice, the Society of Clinical Psychology, Division 12 of the American Psychological Association, invites you to take the survey described below. Once a drug has been approved by the Federal Drug Administration (FDA) as a result of clinical...

Find out more